BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 35294740)

  • 21. Overexpression of ODF1 in Gastrointestinal Tract Neuroendocrine Neoplasms: a Novel Potential Immunohistochemical Biomarker for Well-differentiated Neuroendocrine Tumors.
    Li B; Li X; Mao R; Liu M; Fu L; Shi L; Zhao S; Fu M
    Endocr Pathol; 2021 Jun; 32(2):301-308. PubMed ID: 32869188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases.
    Vanoli A; La Rosa S; Klersy C; Grillo F; Albarello L; Inzani F; Maragliano R; Manca R; Luinetti O; Milione M; Doglioni C; Rindi G; Capella C; Solcia E
    Neuroendocrinology; 2017; 104(2):112-125. PubMed ID: 26910321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Metastatic Patterns Among Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Nonneuroendocrine Carcinomas of Various Primary Organs.
    Park HK; Kwon GY
    J Korean Med Sci; 2023 Mar; 38(11):e85. PubMed ID: 36942393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.
    Uccella S; La Rosa S; Metovic J; Marchiori D; Scoazec JY; Volante M; Mete O; Papotti M
    Endocr Pathol; 2021 Mar; 32(1):192-210. PubMed ID: 33433884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual.
    Deng BY; Yang M; Wen JY; Hou SZ; Chen Y; Tian BL; Liu XB; Zhang Y
    Medicine (Baltimore); 2020 Jan; 99(3):e18736. PubMed ID: 32011453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma.
    Jung CK; Agarwal S; Hang JF; Lim DJ; Bychkov A; Mete O
    Endocr Pathol; 2023 Mar; 34(1):1-22. PubMed ID: 36890425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
    Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
    Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence?
    Helpap B; Köllermann J
    Virchows Arch; 2001 Jan; 438(1):86-91. PubMed ID: 11213840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in Ki67 Labeling Following Treatment of Poorly Differentiated Neuroendocrine Carcinomas: A Potential Diagnostic Pitfall.
    Vyas M; Tang LH; Rekhtman N; Klimstra DS
    Am J Surg Pathol; 2021 Jan; 45(1):25-34. PubMed ID: 33177340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of INSM1 in Diagnosis and Grading of Laryngeal Neuroendocrine Carcinoma.
    Yuan C; Jiao F; Zhai C; Zhang J; Wang S; Zhu L
    Laryngoscope; 2021 Oct; 131(10):E2662-E2668. PubMed ID: 33847383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
    Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
    Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. INSM1 expression in primary and metastatic neuroendocrine neoplasms at distinct locations.
    Wang XQ; Fu J; Zhang YT; Xu Y
    Pathol Res Pract; 2024 Jan; 253():155067. PubMed ID: 38171081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study.
    Kim H; An S; Lee K; Ahn S; Park DY; Kim JH; Kang DW; Kim MJ; Chang MS; Jung ES; Kim JM; Choi YJ; Jin SY; Chang HK; Cho MY; Kang YK; Kang M; Ahn S; Kim YW; Hong SM;
    Cancer Res Treat; 2020 Jan; 52(1):263-276. PubMed ID: 31319641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.
    Umetsu SE; Kakar S; Basturk O; Kim GE; Chatterjee D; Wen KW; Hale G; Shafizadeh N; Cho SJ; Whitman J; Gill RM; Jones KD; Navale P; Bergsland E; Klimstra D; Joseph NM
    Mod Pathol; 2023 Mar; 36(3):100065. PubMed ID: 36788102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Features and Long-Term Survival of Metastatic Hepatic Neuroendocrine Neoplasms Secondary to Gastroenteropancreatic Site: An Analysis by Applying the Grading Classification.
    Yang M; Zeng L; Hou SZ; Ke NW; Tian BL; Liu XB; Xiang B; Zhang Y
    J Oncol; 2020; 2020():6572398. PubMed ID: 33014053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls.
    Konukiewitz B; Jesinghaus M; Kasajima A; Klöppel G
    Virchows Arch; 2022 Feb; 480(2):247-257. PubMed ID: 34647171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.
    Rodriguez EF; Fite JJ; Chowsilpa S; Maleki Z
    Hum Pathol; 2019 Mar; 85():128-135. PubMed ID: 30502379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between WHO Classification and Location- and Functionality-Based Classifications of Neuroendocrine Neoplasms of the Digestive Tract.
    Helderman NC; Suerink M; Kilinç G; van den Berg JG; Nielsen M; Tesselaar MET
    Neuroendocrinology; 2024; 114(2):120-133. PubMed ID: 37690447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.
    Fazio N; Milione M
    Cancer Treat Rev; 2016 Nov; 50():61-67. PubMed ID: 27636009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.